
Research Square (Research Square), Journal Year: 2024, Volume and Issue: unknown
Published: Aug. 28, 2024
Language: Английский
Research Square (Research Square), Journal Year: 2024, Volume and Issue: unknown
Published: Aug. 28, 2024
Language: Английский
Free Radical Biology and Medicine, Journal Year: 2025, Volume and Issue: unknown
Published: Feb. 1, 2025
Language: Английский
Citations
2International Journal of Pharmaceutics, Journal Year: 2024, Volume and Issue: 657, P. 124182 - 124182
Published: April 30, 2024
Language: Английский
Citations
7European Journal of Medicinal Chemistry, Journal Year: 2024, Volume and Issue: 282, P. 117068 - 117068
Published: Nov. 15, 2024
Language: Английский
Citations
4Radiation Oncology, Journal Year: 2025, Volume and Issue: 20(1)
Published: Feb. 7, 2025
Lung cancer patients with comorbid interstitial lung disease (LC-ILD) have an increased risk of developing severe or even fatal radiation pneumonitis after thoracic radiotherapy. However, the underlying mechanisms its pathogenesis are still inconclusive. No approved biomarker medicine is available to prevent pulmonary toxicities in LC-ILD patients. Appropriate management for them remains a challenge clinicians due treatment-related complications. To elucidate histopathological characteristics and molecular responsible this toxicity vivo, C57BL/6J mice were used develop different injury models, including radiation-induced (RILI), bleomycin-induced fibrosis (BIPF), radiation-related (sRRLI) murine model. Biopsy examination was performed on hematoxylin eosin (H&E), Masson's trichrome, immunohistochemistry-stained tissue sections. Changes function measured. RNA extracted from mouse tissues sequenced Illumina Novaseq platform. A model irradiation built based pre-existing ILD induced by BLM administration. Enhanced observed sRRLI model, higher mortality loss within six months compared mono-treatment groups. Autopsy revealed that bilateral diffuse alveolar damage (DAD) overlap exudative, proliferative, fibrosing patterns usually presented The histological phenotypes manifested exudative predominated DAD phase early proliferating pattern late phase. Bioinformatic analysis showed signaling pathways relevant immune cell migration, epithelial development, extracellular structure organization commonly activated models. Furthermore, involvement cells infiltration macrophages CD4 + lymphocytes validated during extensive remodeling group. Delayed effects significantly declined high progressive inflammation lungs contributed complications partial irradiation. hyperactivation inflammatory responses clarified long-term toxicities. More studies needed investigate potential strategies rescue
Language: Английский
Citations
0Inflammopharmacology, Journal Year: 2025, Volume and Issue: unknown
Published: March 4, 2025
Language: Английский
Citations
0Frontiers in Pharmacology, Journal Year: 2025, Volume and Issue: 16
Published: May 8, 2025
Acute lung injury (ALI) and its severe form, acute respiratory distress syndrome (ARDS), represent critical failures with high mortality rates limited treatment options. While the flavonoid rutin exhibits documented anti-inflammatory antioxidant properties, therapeutic mechanisms in ALI/ARDS remain unclear. This study investigated rutin's efficacy against lipopolysaccharide (LPS)-induced ALI mice, a mechanistic focus on cGAS-STING pathway NLRP3 inflammasome activation. Male C57BL/6 mice were divided into Vehicle control, LPS induction, + co-treatment, Rutin monotherapy groups. was induced by intratracheal challenge, administered via gavage. Proteomics analysis, histological evaluation, immunohistochemistry, TUNEL staining, immunofluorescence, RT-qPCR, western blot, ELISA, oxidative stress assays performed to assess effects of ARDS. The proteomic profiling tissues from LPS-challenged identified significant dysregulation proteins integral cascade pyroptotic processes. Gene ontology KEGG analyses underscored pivotal role immune inflammatory responses ALI, particularly cytosolic DNA-sensing NOD-like receptor signaling pathways. administration significantly alleviated LPS-induced injury, reducing stress, apoptosis, proinflammatory cytokine levels (IL-6, IL-1β, TNF-α). Mechanistically, demonstrated dual suppression: 1) inhibiting activation through decreased expression cGAS, STING, phosphorylation TBK1/IRF3 (P<0.05), 2) attenuating NLRP3-mediated pyroptosis downregulation NLRP3-ASC-caspase1-GSDMD (P<0.05). Pharmacological STING inhibition (C-176) validated cGAS-STING-NLRP3 regulatory hierarchy pathogenesis. These findings elucidate novel mechanism coordinated suppression axis, positioning it as promising candidate for intervention.
Language: Английский
Citations
0Prostaglandins Leukotrienes and Essential Fatty Acids, Journal Year: 2024, Volume and Issue: 203, P. 102652 - 102652
Published: April 1, 2024
Language: Английский
Citations
2Molecular Medicine Reports, Journal Year: 2024, Volume and Issue: 31(1)
Published: Nov. 4, 2024
Acute lung injury (ALI) or acute respiratory distress syndrome (ARDS) is a common disease characterized by hypoxemia and distress. It associated with high morbidity mortality. Due to the complex pathogenesis of ALI, clinical management patients ALI/ARDS challenging, resulting in numerous post‑treatment sequelae compromising quality life patients. Macrophages, as class innate immune cells, play an important role ALI/ARDS. In recent years, functions phenotypes macrophages have been better understood due development flow cytometry, immunofluorescence, single‑cell sequencing spatial genomics. However, no macrophage‑targeted drugs for treatment currently exist practice. Natural products are drug development, it has shown that natural compounds from herbal medicine can alleviate caused various factors modulating macrophage abnormalities. present review, modulate abnormalities treat introduced, their mechanisms action, discovered previous five years (2019‑2024), presented. This will provide novel ideas directions further research, develop new
Language: Английский
Citations
1Journal of Biomaterials and Tissue Engineering, Journal Year: 2024, Volume and Issue: 14(3), P. 115 - 129
Published: March 1, 2024
The respiratory system plays a crucial role in human life activities, and acute lung injury (ALI) is highly fatal disease caused by variety of reasons. At present, although several preclinical studies have demonstrated the efficacy pharmacological interventions, supportive care mechanical ventilation still remain primary modalities for managing ALI, there are no safe effective treatments ALI. With rapid development nanotechnology, nanobiomedicines with different structures functional moieties been well-designed based on their targeting ability pathophysiology In this review, it summarizes challenges faced ALI therapy, introduces including liposomes, polymers, inorganic materials, others to bring therapeutic effects discusses research progress recent years nanobiomedicine applied injury. Finally, provides summary prospect application
Language: Английский
Citations
0Research Square (Research Square), Journal Year: 2024, Volume and Issue: unknown
Published: Aug. 28, 2024
Language: Английский
Citations
0